Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced key organizational changes within its biologics business to further align its organization with customer demand for integrated and comprehensive, end-to-end biologics solutions. Further underlining Catalent's commitment to continued growth and investment in biologics, the reorganization follows its 2017 acquisition of Cook Pharmica LLC, and with it the addition of its award-winning 875,000 square-foot facility in Bloomington, Indiana to provide comprehensive biologics development, analytical services, and drug substance and drug product manufacturing. Tedd Green, former President of Cook Pharmica, becomes Senior Vice President of Catalent Biologics, and will have responsibility for the entire biologics business.